Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes:

Hashmat Sayed Zohori Bahrami1, Peter Godsk Jørgensen2, Jens Dahlgaard Hove3

  • 1Department of Clinical and Translational Research, Steno Diabetes Center Copenhagen, Borgmester Ib Juuls Vej 83, 2730 Herlev, Denmark; Department of Cardiology, Copenhagen University Hospital, Amager & Hvidovre, Kettegård Alle 30, 2650 Hvidovre, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark.

Insights

Chronic inflammation, measured by biomarkers like IL-6, suPAR, and hsCRP, is linked to subclinical left ventricular dysfunction in type 1 diabetes (T1D). These findings suggest inflammation may drive heart problems in T1D patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Type 1 diabetes (T1D) is associated with an increased risk of cardiovascular complications.
  • Subclinical left ventricular dysfunction can precede overt heart failure in T1D.
  • Chronic inflammation is implicated in the pathogenesis of various diabetic complications.

Purpose of the Study:

  • To investigate the association between specific inflammatory biomarkers and subclinical left ventricular dysfunction in individuals with T1D.
  • To determine if biomarkers such as interleukin-6 (IL-6), soluble-urokinase-plasminogen-activator-receptor (suPAR), and high-sensitivity C-reactive-protein (hsCRP) correlate with echocardiographic measures of cardiac function.
  • To explore the combined effect of these inflammatory markers on left ventricular function.

Main Methods:

  • A cross-sectional study was conducted on 962 individuals with T1D and no known heart disease.
  • Blood levels of IL-6, suPAR, and hsCRP were measured and categorized based on upper quartiles.
  • Echocardiographic parameters, including E/e' (primary) and global longitudinal strain (GLS) (secondary), were assessed. Linear regression analysis was used, adjusting for clinical variables.

Main Results:

  • All examined inflammatory biomarkers (IL-6, suPAR, hsCRP) were independently associated with increased E/e' and decreased GLS.
  • Elevated levels of combined biomarkers showed stronger associations with left ventricular dysfunction.
  • Specifically, elevated IL-6 and suPAR were linked to significantly worse cardiac function, as were all three elevated biomarkers.

Conclusions:

  • Chronic inflammation, indicated by elevated IL-6, suPAR, and hsCRP, is independently associated with subclinical left ventricular dysfunction in T1D.
  • These inflammatory markers may play a significant role in the development of myocardial dysfunction in individuals with type 1 diabetes.
  • Targeting inflammation could be a potential strategy to prevent cardiac complications in T1D.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41